Epigenomic alterations define lethal CIMP-positive ependymomas of infancy (original) (raw)

Accession codes

Accessions

Gene Expression Omnibus

Data deposits

Illumina 450K CpG Methylation array data, NimbleGen 385K CpG Island Plus array data, and ChIP-seq data have been deposited at the Gene Expression Omnibus (GEO: http://www.ncbi.nlm.nih.gov/geo/) as a GEO super-series under the accession number GSE43353. Whole-genome and whole-exome sequencing data have been deposited in the European Genome-Phenome Archive (EGA: https://www.ebi.ac.uk/ega/) hosted by the EBI, under the accession number EGAS00001000443.

References

1. Taylor, M. D. et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8, 323–335 (2005)
   Article CAS PubMed Google Scholar
2. Merchant, T. E. et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 10, 258–266 (2009)
   Article PubMed PubMed Central Google Scholar
3. Bouffet, E. & Foreman, N. Chemotherapy for intracranial ependymomas. Childs Nerv. Syst. 15, 563–570 (1999)
   Article CAS PubMed Google Scholar
4. Bouffet, E. et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int. J. Radiat. Oncol. Biol. Phys. 83, 1541–1548 (2012)
   Article PubMed Google Scholar
5. Johnson, R. A. et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466, 632–636 (2010)
   ADS CAS PubMed PubMed Central Google Scholar
6. Witt, H. et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20, 143–157 (2011)
   CAS PubMed PubMed Central Google Scholar
7. Wani, K. et al. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. 123, 727–738 (2012)
   Article CAS PubMed PubMed Central Google Scholar
8. Atkinson, J. M. et al. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell 20, 384–399 (2011)
   Article CAS PubMed PubMed Central Google Scholar
9. Jones, D. T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100–105 (2012)
   Article ADS CAS PubMed PubMed Central Google Scholar
10. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013)
    Article ADS CAS PubMed PubMed Central Google Scholar
11. Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589–1598 (2012)
    Article CAS PubMed PubMed Central Google Scholar
12. Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462–477 (2013)
    Article CAS PubMed PubMed Central Google Scholar
13. Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012)
    Article ADS CAS Google Scholar
14. Muzny, D. M. et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012)
    Article ADS CAS Google Scholar
15. Peifer, M. et al. Integrative genomic analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics 44, 1104–1110 (2012)
    Article CAS PubMed PubMed Central Google Scholar
16. Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
17. Hammerman, P. S. et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012)
    Article ADS CAS Google Scholar
18. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012)
    Article CAS PubMed PubMed Central Google Scholar
19. Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011)
    Article ADS CAS PubMed PubMed Central Google Scholar
20. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107–1120 (2012)
    Article CAS PubMed PubMed Central Google Scholar
21. Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011)
    Article CAS Google Scholar
22. Pugh, T. J. et al. The genetic landscape of high-risk neuroblastoma. Nature Genetics 45, 279–284 (2013)
    Article CAS PubMed PubMed Central Google Scholar
23. Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011)
    Article ADS CAS PubMed PubMed Central Google Scholar
24. Lee, R. S. et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J. Clin. Invest. 122, 2983–2988 (2012)
    Article CAS PubMed PubMed Central Google Scholar
25. Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 329–334 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
26. Northcott, P. A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49–56 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
27. Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
28. Robinson, G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43–48 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
29. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012)
    Article ADS CAS PubMed Google Scholar
30. Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nature Genet. 45, 12–17 (2013)
    Article CAS PubMed Google Scholar
31. Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nature Genet. 44, 251–253 (2012)
    Article CAS PubMed Google Scholar
32. Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998)
    Article ADS CAS PubMed Google Scholar
33. Northcott, P. A. et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nature Genet. 41, 465–472 (2009)
    Article CAS PubMed Google Scholar
34. Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510–522 (2010)
    Article CAS PubMed PubMed Central Google Scholar
35. Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genet. 39, 237–242 (2007)
    Article CAS PubMed Google Scholar
36. Kantarjian, H. et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106, 1794–1803 (2006)
    Article CAS PubMed Google Scholar
37. Tan, J. et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 21, 1050–1063 (2007)
    Article CAS PubMed PubMed Central Google Scholar
38. McCabe, M. T. et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108–112 (2012)
    Article ADS CAS PubMed Google Scholar
39. Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
40. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343–348 (2011)
    Article ADS CAS PubMed PubMed Central Google Scholar
41. Fang, F. et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci. Transl. Med. 3, 75ra25 (2011)
    Article PubMed PubMed Central Google Scholar
42. Roman-Gomez, J. et al. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J. Clin. Oncol. 23, 7043–7049 (2005)
    Article CAS PubMed Google Scholar
43. Zouridis, H. et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci. Transl. Med. 4, 156ra140 (2012)
    Article PubMed Google Scholar
44. Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681–8686 (1999)
    Article ADS CAS PubMed PubMed Central Google Scholar
45. Weisenberger, D. J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet. 38, 787–793 (2006)
    Article CAS PubMed Google Scholar
46. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 40, 499–507 (2008)
    Article CAS PubMed Google Scholar
47. Down, T. A. et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nature Biotechnol. 26, 779–785 (2008)
    Article CAS Google Scholar
48. Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958–970 (2008)
    Article CAS PubMed PubMed Central Google Scholar
49. Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nature Genet. 43, 768–775 (2011)
    Article CAS PubMed Google Scholar
50. Gallo, M. et al. A tumorigenic MLL-homeobox network in human glioblastoma stem cells. Cancer Res. 73, 417–427 (2013)
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

M.D.T. holds a Canadian Institutes of Health Research (CIHR) Clinician-Scientist Phase II Award, was a Sontag Foundation Distinguished Scholar, and is supported by The Garron Family Chair in Childhood Cancer Research. M.D.T. is supported by grants from the Cure Search Foundation, The Younger Foundation, the National Institutes of Health (R01CA148699 and R01CA159859), The Pediatric Brain Tumor Foundation, The Canadian Cancer Society, The Terry Fox Research Institute, and Brainchild. S.M., K.M.W. and A.D. are supported by Vanier Scholarships from CIHR. S.M. would like to thank K. Mack, R. Mack, S. Mack and K. Bertrand for their support of this project. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. This work was also supported by a Program Project Grant from the Terry Fox Research Institute, and a Grand Challenge Award from CureSearch for Children’s Cancer. Additionally, this work was supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFNplus 01GS0883). This study was supported by grants from the Sander Foundation and DKTK (Molecular Diagnostics of Pediatric Malignancies). For technical support and expertise of next-generation sequencing efforts we thank the DKFZ Genomics and Proteomics Core Facility, The EMBL Genomics Core Facility, and The Centre for Applied Genomics (Toronto). We thank S. Archer for technical writing and C. Smith for artwork. We thank A. Wittmann, L. Sieber and L. Linke for clinical assistance.

Author information

Author notes

1. S. C. Mack and H. Witt: These authors contributed equally to this work.

Authors and Affiliations

1. Developmental & Stem Cell Biology Program, Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada,
   S. C. Mack, X. Wang, M. Gallo, L. Garzia, K. Zayne, V. Ramaswamy, D. J. H. Shih, R. Head, M. Remke, C. C. Faria, M. Barszczyk, A. M. Dubuc, J. Peacock, K. C. Bertrand, S. Agnihotri, F. M. G. Cavalli, I. Clarke, K. Nethery-Brokx, X. Wu, Y. Yao, P. Sin-Chan, J. Zuccaro, L. Lau, S. Pereira, P. Castelo-Branco, S. W. Scherer, A. Huang, U. Tabori, C. Hawkins, P. N. Kongkham, J. T. Rutka, P. B. Dirks & M. D. Taylor
2. Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada,
   S. C. Mack, X. Wang, V. Ramaswamy, D. J. H. Shih, M. Remke, M. Barszczyk, A. M. Dubuc, J. Peacock, K. C. Bertrand, Y. Yao, C. Hawkins, P. N. Kongkham, J. T. Rutka, P. B. Dirks & M. D. Taylor
3. Division of Neurosurgery, University of Toronto, Toronto, Ontario M5S 1A8, Canada,
   S. C. Mack, P. N. Kongkham, J. T. Rutka, P. B. Dirks & M. D. Taylor
4. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany,
   H. Witt, D. T. W. Jones, M. Ryzhova, S. Stark, H. Seker-Cin, S. Hutter, P. Johann, S. Bender, T. Tzaridis, P. A. Northcott, M. Kool & S. M. Pfister
5. Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg 69120, Germany,
   H. Witt, T. Milde, A. E. Kulozik, O. Witt & S. M. Pfister
6. German Cancer Consortium (DKTK), Heidelberg 69120, Germany,
   H. Witt, R. M. Piro, L. Gu, A. M. Stütz, N. Jäger, D. T. W. Jones, M. Sill, M. Ryzhova, T. Zichner, S. Stark, H. Seker-Cin, S. Hutter, P. Johann, S. Bender, V. Hovestadt, T. Tzaridis, P. A. Northcott, T. Milde, A. E. Kulozik, A. von Deimling, O. Witt, M. Kool, R. Eils, P. Lichter, S. M. Pfister & A. Korshunov
7. Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,
   R. M. Piro, V. Hovestadt & P. Lichter
8. Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,
   L. Gu, N. Jäger & R. Eils
9. Department of Molecular Genetics, Banting and Best Department of Medical Research, The Donnelly Centre, University of Toronto, Toronto, Ontario M4N 1X8, Canada,
   S. Zuyderduyn & G. D. Bader
10. Genome Biology, European Molecular Biology, Laboratory Meyerhofstr. 1, Heidelberg 69117, Germany,
    A. M. Stütz, T. Zichner & J. O. Korbel
11. Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, 03756, New Hampshire, USA
    X. Zhang
12. Division of Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,
    M. Sill
13. Department of Neurology, Harvard Medical School, Children’s Hospital Boston, MIT, Boston, Massachusetts 02115, USA,
    T. J. Pugh & S. L. Pomeroy
14. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA
    K. M. Wani & K. D. Aldape
15. Ontario Cancer Institute, Princess Margaret Cancer Centre–University Health Network, Toronto, Ontario M5G 1L7, Canada,
    S. D. Bailey & M. Lupien
16. Ontario Institute for Cancer Research, Toronto, Ontario M5G 1L7, Canada,
    S. D. Bailey & M. Lupien
17. Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, Collegeville, 19426, Pennsylvania, USA
    C. L. Creasy & S. K. Verma
18. Department of Oncogenomics, Academic Medical Center, Amsterdam 1105, The Netherlands,
    J. Koster
19. CCU Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,
    T. Milde & O. Witt
20. Department of Microbiology & Immunology, Centre for High-Throughput Biology, University of British Columbia, Vancouver, V6T 1Z4 British Columbia, Canada,
    M. Hirst
21. Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada,
    M. Hirst & M. A. Marra
22. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada,
    M. A. Marra
23. Department of Pediatrics and National Capital Consortium, Uniformed Services University, Bethesda, 20814, Maryland, USA
    S. S. Roberts
24. Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, 84132, Utah, USA
    D. Fults
25. Pediatric Neurosurgery, Catholic University Medical School, Gemelli Hospital, Rome 00168, Italy,
    L. Massimi
26. Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, 94305, California, USA
    Y. J. Cho
27. Department of Pediatrics, Virginia Commonwealth, Richmond, 23298-0646, Virginia, USA
    T. Van Meter
28. Department of Pathology, University of Warsaw, Children’s Memorial Health Institute University of Warsaw, Warsaw 04-730, Poland,
    W. Grajkowska
29. Division of Anatomical Pathology, Department of Pathology and Molecular Medicine, McMaster University, Hamilton General Hospital, Hamilton, Ontario L8S 4K1, Canada,
    B. Lach
30. Department of Neuropathology Ruprecht-Karls-University Heidelberg, Institute of Pathology, Heidelberg 69120, Germany,
    A. von Deimling
31. University of Michigan Cell and Developmental Biology, Ann Arbor, 48109-2200, Michigan, USA
    X. Fan & A. Korshunov
32. Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, 48109, Michigan, USA
    X. Fan & K. M. Muraszko
33. Department of Neurosurgery, University of California San Francisco, San Francisco, 94143-0112, California, USA
    N. Gupta
34. Departments of Neurology, Pediatrics, and Neurosurgery, University of California, San Francisco, The Helen Diller Family Cancer Research Building, San Francisco, California 94158, USA,
    J. Phillips & W. A. Weiss
35. Department of Neuro-oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada,
    A. Huang, U. Tabori & E. Bouffet
36. Department of Haematology and Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada,
    D. Malkin
37. Departments of Pediatrics and Human Genetics, McGill University and the McGill University Health Center Research Institute, Montreal, Quebec H3Z 2Z3, Canada,
    N. Jabado
38. Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1X8, Canada,
    M. Lupien
39. Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada,
    P. B. Dirks
40. CCU Neuropathology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,
    A. Korshunov

Authors

1. S. C. Mack
   You can also search for this author inPubMed Google Scholar
2. H. Witt
   You can also search for this author inPubMed Google Scholar
3. R. M. Piro
   You can also search for this author inPubMed Google Scholar
4. L. Gu
   You can also search for this author inPubMed Google Scholar
5. S. Zuyderduyn
   You can also search for this author inPubMed Google Scholar
6. A. M. Stütz
   You can also search for this author inPubMed Google Scholar
7. X. Wang
   You can also search for this author inPubMed Google Scholar
8. M. Gallo
   You can also search for this author inPubMed Google Scholar
9. L. Garzia
   You can also search for this author inPubMed Google Scholar
10. K. Zayne
    You can also search for this author inPubMed Google Scholar
11. X. Zhang
    You can also search for this author inPubMed Google Scholar
12. V. Ramaswamy
    You can also search for this author inPubMed Google Scholar
13. N. Jäger
    You can also search for this author inPubMed Google Scholar
14. D. T. W. Jones
    You can also search for this author inPubMed Google Scholar
15. M. Sill
    You can also search for this author inPubMed Google Scholar
16. T. J. Pugh
    You can also search for this author inPubMed Google Scholar
17. M. Ryzhova
    You can also search for this author inPubMed Google Scholar
18. K. M. Wani
    You can also search for this author inPubMed Google Scholar
19. D. J. H. Shih
    You can also search for this author inPubMed Google Scholar
20. R. Head
    You can also search for this author inPubMed Google Scholar
21. M. Remke
    You can also search for this author inPubMed Google Scholar
22. S. D. Bailey
    You can also search for this author inPubMed Google Scholar
23. T. Zichner
    You can also search for this author inPubMed Google Scholar
24. C. C. Faria
    You can also search for this author inPubMed Google Scholar
25. M. Barszczyk
    You can also search for this author inPubMed Google Scholar
26. S. Stark
    You can also search for this author inPubMed Google Scholar
27. H. Seker-Cin
    You can also search for this author inPubMed Google Scholar
28. S. Hutter
    You can also search for this author inPubMed Google Scholar
29. P. Johann
    You can also search for this author inPubMed Google Scholar
30. S. Bender
    You can also search for this author inPubMed Google Scholar
31. V. Hovestadt
    You can also search for this author inPubMed Google Scholar
32. T. Tzaridis
    You can also search for this author inPubMed Google Scholar
33. A. M. Dubuc
    You can also search for this author inPubMed Google Scholar
34. P. A. Northcott
    You can also search for this author inPubMed Google Scholar
35. J. Peacock
    You can also search for this author inPubMed Google Scholar
36. K. C. Bertrand
    You can also search for this author inPubMed Google Scholar
37. S. Agnihotri
    You can also search for this author inPubMed Google Scholar
38. F. M. G. Cavalli
    You can also search for this author inPubMed Google Scholar
39. I. Clarke
    You can also search for this author inPubMed Google Scholar
40. K. Nethery-Brokx
    You can also search for this author inPubMed Google Scholar
41. C. L. Creasy
    You can also search for this author inPubMed Google Scholar
42. S. K. Verma
    You can also search for this author inPubMed Google Scholar
43. J. Koster
    You can also search for this author inPubMed Google Scholar
44. X. Wu
    You can also search for this author inPubMed Google Scholar
45. Y. Yao
    You can also search for this author inPubMed Google Scholar
46. T. Milde
    You can also search for this author inPubMed Google Scholar
47. P. Sin-Chan
    You can also search for this author inPubMed Google Scholar
48. J. Zuccaro
    You can also search for this author inPubMed Google Scholar
49. L. Lau
    You can also search for this author inPubMed Google Scholar
50. S. Pereira
    You can also search for this author inPubMed Google Scholar
51. P. Castelo-Branco
    You can also search for this author inPubMed Google Scholar
52. M. Hirst
    You can also search for this author inPubMed Google Scholar
53. M. A. Marra
    You can also search for this author inPubMed Google Scholar
54. S. S. Roberts
    You can also search for this author inPubMed Google Scholar
55. D. Fults
    You can also search for this author inPubMed Google Scholar
56. L. Massimi
    You can also search for this author inPubMed Google Scholar
57. Y. J. Cho
    You can also search for this author inPubMed Google Scholar
58. T. Van Meter
    You can also search for this author inPubMed Google Scholar
59. W. Grajkowska
    You can also search for this author inPubMed Google Scholar
60. B. Lach
    You can also search for this author inPubMed Google Scholar
61. A. E. Kulozik
    You can also search for this author inPubMed Google Scholar
62. A. von Deimling
    You can also search for this author inPubMed Google Scholar
63. O. Witt
    You can also search for this author inPubMed Google Scholar
64. S. W. Scherer
    You can also search for this author inPubMed Google Scholar
65. X. Fan
    You can also search for this author inPubMed Google Scholar
66. K. M. Muraszko
    You can also search for this author inPubMed Google Scholar
67. M. Kool
    You can also search for this author inPubMed Google Scholar
68. S. L. Pomeroy
    You can also search for this author inPubMed Google Scholar
69. N. Gupta
    You can also search for this author inPubMed Google Scholar
70. J. Phillips
    You can also search for this author inPubMed Google Scholar
71. A. Huang
    You can also search for this author inPubMed Google Scholar
72. U. Tabori
    You can also search for this author inPubMed Google Scholar
73. C. Hawkins
    You can also search for this author inPubMed Google Scholar
74. D. Malkin
    You can also search for this author inPubMed Google Scholar
75. P. N. Kongkham
    You can also search for this author inPubMed Google Scholar
76. W. A. Weiss
    You can also search for this author inPubMed Google Scholar
77. N. Jabado
    You can also search for this author inPubMed Google Scholar
78. J. T. Rutka
    You can also search for this author inPubMed Google Scholar
79. E. Bouffet
    You can also search for this author inPubMed Google Scholar
80. J. O. Korbel
    You can also search for this author inPubMed Google Scholar
81. M. Lupien
    You can also search for this author inPubMed Google Scholar
82. K. D. Aldape
    You can also search for this author inPubMed Google Scholar
83. G. D. Bader
    You can also search for this author inPubMed Google Scholar
84. R. Eils
    You can also search for this author inPubMed Google Scholar
85. P. Lichter
    You can also search for this author inPubMed Google Scholar
86. P. B. Dirks
    You can also search for this author inPubMed Google Scholar
87. S. M. Pfister
    You can also search for this author inPubMed Google Scholar
88. A. Korshunov
    You can also search for this author inPubMed Google Scholar
89. M. D. Taylor
    You can also search for this author inPubMed Google Scholar

Contributions

S.C.M., H.W., M.D.T., A.K. and S.M.P. conceived and led the study. S.C.M. performed sample preparation, data acquisition and bioinformatic analysis related to DNA methylation, ChIP-seq and transcriptional profiling experiments. S.C.M. also performed western blot analysis and contributed to in vitro and in vivo experiments. H.W. led whole-genome sequencing, whole-exome sequencing and whole-genome bisulphite sequencing efforts, with analytical support from R.M.P., L. Gu., N. Jäger, D.T.W.J., S.S., S.H., T.Z., A.M.S., T.J.P., M.S., H.S.-C., T.T., V.H. and J.O.K. S.Z. and G.D.B. developed and applied pathway analysis methods for all data sets in this study. K.N.-B., M.G., L. Garzia, K.Z., X. Wang, M.B., S.B., P.J., X. Wu, K.C.B., T.M., J.Z., P.S.-C., C.C.F., P.C.-B., Y.Y. and S.A. performed in vitro, in vivo and molecular/biochemical experiments central to the project. DNA methylation and ChIP-seq bioinformatic analysis and experimental design were supported by X.Z., V.R., P.N.K., A.M.D., P.A.N., D.J.H.S., J.P., M. Remke, F.M.G.C., L.L., S.P., S.W.S., S.D.B., M.G., J.K., I.C., R.H. and P.B.D., developed and characterized ependymoma primary cultures, and assisted with in vitro and in vivo experiments. C.L.C. and S.K.V. developed the EZH2 compounds and provided inhibitors for experimentation. S.S.R., L.M., Y.J.C., T.V.M., W.G., B.L., M. Ryzhova, A.K., N.G., J.P., K.W. and K.D.A. provided patient samples and clinical details that made this study possible. M.H., M.A.M., M.L., D.F., A.E.K., A.v.D., O.W., D.M., X.F., K.M.M., M.K., S.L.P., E.B., W.A.W., A.H., U.T., C.H., J.T.R., N. Jabado, J.O.K., R.E., P.L., G.D.B., K.D.A., P.B.D. and S.M.P. provided valuable input regarding study design, data analysis and interpretation of results. M.D.T., S.C.M., H.W., A.K. and S.M.P. wrote the manuscript. M.D.T. and S.M.P. provided financial and technical infrastructure and oversaw the study. M.D.T. and A.K. are joint senior authors and project co-leaders.

Corresponding authors

Correspondence toA. Korshunov or M. D. Taylor.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

PowerPoint slides

Rights and permissions

About this article

Cite this article

Mack, S., Witt, H., Piro, R. et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.Nature 506, 445–450 (2014). https://doi.org/10.1038/nature13108

Download citation

• Received: 10 March 2013
• Accepted: 28 January 2014
• Published: 19 February 2014
• Issue Date: 27 February 2014
• DOI: https://doi.org/10.1038/nature13108